A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy
Clinical trial NCT00708201 · COMPLETED
Trial details
- NCT number
- NCT00708201
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-01-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.